Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Advanced Drug Delivery Reviews
C A LipinskiP J Feeney

Abstract

Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP > 4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements.

References

Sep 1, 1992·Journal of Pharmaceutical Sciences·N Bodor, M J Huang
Mar 24, 1972·Nature·B E Cohen, A D Bangham
Dec 1, 1984·Journal of Medicinal Chemistry·P R AndrewsJ L Martin
Aug 1, 1980·Journal of Pharmaceutical Sciences·S H Yalkowsky, S C Valvani
Mar 1, 1995·Medicinal Research Reviews·K M HillgrenR T Borchardt
Jul 1, 1995·Journal of Chemical Information and Computer Sciences·H ChowS H Yalkowsky
Sep 1, 1994·Journal of Pharmaceutical Sciences·M H AbrahamR C Mitchell

❮ Previous
Next ❯

Citations

Jul 17, 2008·Comparative and Functional Genomics·Thomas A White, Douglas B Kell
Apr 20, 2011·Analytical and Bioanalytical Chemistry·Francesca ManciniVincenza Andrisano
Oct 5, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Walter MierUwe Haberkorn
Jun 3, 2009·Cancer Chemotherapy and Pharmacology·Chao XuDonald E Mager
Jul 10, 2012·Current Microbiology·Fernanda da C SantosMaria C B V de Souza
Jun 25, 2010·Archives of Dermatological Research·Martin Rostami-YazdiUlrich Mrowietz
Oct 6, 2010·Parasitology Research·David MorenoCarmen Sanmartín
Dec 22, 2010·Protoplasma·Pramod KataraVinay Sharma
Dec 19, 2007·Journal of Molecular Modeling·Derek J CashmanEdwin A Lewis
Dec 11, 2008·Journal of Molecular Modeling·Anna Maria AlmericoAntonino Lauria
Mar 2, 2011·Journal of Molecular Modeling·Aldo Segura-CabreraMario A Rodríguez-Pérez
Jun 15, 2011·Journal of Molecular Modeling·Tihomir TomašićLucija Peterlin Mašič
Dec 6, 2011·Journal of Molecular Modeling·Homa AzizianMassoud Amanlou
Dec 12, 2012·Journal of Molecular Modeling·Chandran RemyaChittalakkottu Sadasivan
Jan 15, 2013·Journal of Molecular Modeling·Kalarickal Vijayan DileepChittalakkottu Sadasivan
Apr 10, 2012·Annals of Biomedical Engineering·Jack D WangMohamed ElSayed
Mar 28, 2012·Bulletin of Experimental Biology and Medicine·V P ZherdevD V Bastrygin
Nov 18, 2005·Journal of Computer-aided Molecular Design·A VarnekV P Solov'ev
Apr 20, 2006·Journal of Computer-aided Molecular Design·Dhilon S Patel, Prasad V Bharatam
Apr 29, 2006·Journal of Computer-aided Molecular Design·Sai Chetan K SukuruLeslie A Kuhn
Jan 16, 2008·Journal of Computer-aided Molecular Design·Rommie E AmaroJ Andrew McCammon
Feb 7, 2008·Journal of Computer-aided Molecular Design·Anthony Nicholls
Jan 25, 2008·Journal of Computer-aided Molecular Design·Christof GerlachAndrea Zaliani
Oct 23, 2008·Journal of Computer-aided Molecular Design·Rubén Gil-RedondoAngel R Ortiz
May 30, 2009·Journal of Computer-aided Molecular Design·Anvita GuptaKothandaraman Seshadri
Jun 30, 2009·Journal of Computer-aided Molecular Design·Andrea ZalianiMatthias Rarey
Nov 6, 2009·Journal of Computer-aided Molecular Design·Bjoern A KruegerGisbert Schneider
May 11, 2010·Journal of Computer-aided Molecular Design·Lourdes Cucurull-Sanchez
May 25, 2010·Journal of Computer-aided Molecular Design·Yuko OkamotoHironori Kokubo
Feb 24, 2011·Journal of Computer-aided Molecular Design·Tim KnehansSubhash G Vasudevan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.